The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Harpoon Therapeutics Inc COM NEW
HARP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
15 minutes delayed
Get Report
Comment
Harpoon Therapeutics Inc COM NEW (HARP) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Harpoon Therapeutics Inc COM NEW (NASDAQ:HARP) Stock
Harpoon Therapeutics Inc COM NEW Stock (NASDAQ: HARP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 26, 2024
Oppenheimer Maintains Outperform on Harpoon T...
Benzinga Newsdesk
Monday, February 26, 2024
Analyst Scoreboard: 4 Ratings For Harpoon Therapeutics
Benzinga Insights
Thursday, February 01, 2024
Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth
Vandana Singh
Monday, January 29, 2024
Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings
Surbhi Jain
Tuesday, January 16, 2024
Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights
Benzinga Insights
TD Cowen Downgrades Harpoon Therapeutics to M...
Benzinga Newsdesk
Monday, January 08, 2024
Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
Avi Kapoor
HC Wainwright & Co. Downgrades Harpoon Therap...
Benzinga Newsdesk
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
Avi Kapoor
Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal
Vandana Singh
Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics
Benzinga Insights
US Stocks Mixed; Nasdaq Jumps Over 100 Points
Avi Kapoor
Harpoon Therapeutics shares are trading highe...
Benzinga Newsdesk
Market-Moving News for January 8th
Benzinga Newsdesk
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Top 3 Health Care Stocks That May Plunge In January
Avi Kapoor
Merck To Acquire Harpoon Therapeutics For $23...
Benzinga Newsdesk
Why Is Cancer Focused Harpoon Therapeutics Stock Shooting Higher Today?
Vandana Singh
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Avi Kapoor
Bloomberg Reported Earlier: Merck Is In Advanced Talks To Buy Harpoon Therapeutics For ~$23/Share
Charles Gross
Friday, January 05, 2024
Oppenheimer Initiates Coverage On Harpoon The...
Benzinga Newsdesk
Tuesday, December 19, 2023
Harpoon Therapeutics Abstract for HPN328 In S...
Benzinga Newsdesk
Wednesday, December 13, 2023
Expert Ratings for Harpoon Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Harpoon ...
Benzinga Newsdesk
Tuesday, December 12, 2023
Harpoon Therapeutics Presented HPN217 Phase 1...
Benzinga Newsdesk
Friday, December 08, 2023
Harpoon Therapeutics, Inc. Files Prospectus F...
Benzinga Newsdesk
Monday, November 27, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Monday, November 20, 2023
TD Cowen Initiates Coverage On Harpoon Therap...
Benzinga Newsdesk
Thursday, November 09, 2023
Harpoon Therapeutics Q3 EPS $(0.46) Beats $(3...
Benzinga Newsdesk
Friday, November 03, 2023
Harpoon Therapeutics 13G Filing Shows Commodo...
Benzinga Newsdesk
Thursday, November 02, 2023
Harpoon Therapeutics Abstract For HPN217 Acce...
Benzinga Newsdesk
Monday, October 30, 2023
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 24, 2023
Citigroup Maintains Buy on Harpoon Therapeuti...
Benzinga Newsdesk
Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, October 23, 2023
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
What's Going On With Harpoon Therapeutics Stock Monday?
Adam Eckert
Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Harpoon Therapeutics Announces Up To $150M Pr...
Benzinga Newsdesk
Saturday, October 21, 2023
Harpoon Therapeutics Announced Confirmed Response Rate 35% (11/31), Across All Tumor Types And Patient Cohorts Treated With 1 Mg Priming Dose, Including Three Confirmed, Complete Responses In Phase 1/2 Clinical Trial of T Cell Engager HPN328
Charles Gross
Wednesday, October 18, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 09, 2023
Harpoon Therapeutics To Present Interim Toler...
Benzinga Newsdesk
Thursday, September 28, 2023
Harpoon Therapeutics To Present HPN217 Interi...
Benzinga Newsdesk
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 18, 2023
Citigroup Maintains Buy on Harpoon Therapeuti...
Benzinga Newsdesk
Show More